PM

Peeyush Mehrotra

Active Director Director DIN 06547019
DIN 06547019 First appointment May 2013 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2013
Shareholding value •••• Premium profile

About Peeyush Mehrotra

Data last updated:

Peeyush Mehrotra is a Director at Florenz Pharma Private Limited (since 2013). The company operates in Healthcare. Florenz Pharma Private Limited reported revenue of ₹19.3 Lakh (FY 2017).

DIN 06547019
Primary Designation Director
Industry Healthcare
First Appointment 06 May 2013
Oldest Company Age 13 yrs
Largest company Florenz Pharma Private Limited · ₹19.3 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Florenz Pharma Private Limited U85191UP2013PTC056746
Director06 May 20132013₹19.3 Lakh (FY 2017)Active

Board colleagues of Peeyush Mehrotra

Directorship timeline

Open interactive timeline →
Florenz Pharma Private Limited
Premium access

Shareholding and investment profile for Peeyush Mehrotra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Peeyush Mehrotra

Peeyush Mehrotra currently holds 1 directorship: Florenz Pharma Private Limited (Director, since 06 May 2013, revenue ₹19.3 Lakh (FY 2017)).

Peeyush Mehrotra was first appointed on 06 May 2013 as Director at Florenz Pharma Private Limited.

The current boards of Peeyush Mehrotra's companies include Jyoti Srivastava (Florenz Pharma Private Limited), Moni Mehrotra (Florenz Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available